About
Per gilead.com, Anthony Welters has served on Gilead's Board of Directors since 2020, and in May 2024 the independent directors unanimously appointed him Lead Independent Director in recognition of his leadership experience and in-depth knowledge of Gilead.
He has significant leadership experience on other public boards and extensive experience in the health insurance and managed care industry, with a demonstrated commitment to delivering healthcare to underserved communities.
Roles
Gilead Sciences, Inc.
Lead Independent Director · Current role
2020–present
UnitedHealth Group
Senior Adviser to the Office of the CEO
—
External Roles
CINQ Care
Chairman and Chief Executive Officer
—
Director Compensation
FY 2025Fees earned or paid in cash
$180,041
Stock awards
$149,932
FormRSUs (1,516 shares granted May 7, 2025, vested immediately)
Option awards
$149,989
Total
$479,962
Also at Gilead Sciences, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.